Search Login Register
mycophenolate mofetil
(Cellcept)
Summary
Description:
mycophenolic acid that is chemically altered by the addition of morpholinoethylester; selective and reversible inhibitor of inosine monophosphate dehydrogenase
Also Known As:
Cellcept; RS 61443; RS-61443; mycophenolate mofetil hydrochloride; mycophenolic acid morpholinoethyl ester
Networked: 2050
relevant articles (251 outcomes,
244 trials/studies)
for this Drug
Key Diseases for which mycophenolate mofetil is
Relevant
-
Lupus Nephritis
:
45 outcomes 59 studies in 213 results
-
Nephrotic Syndrome (Syndrome, Nephrotic)
:
14 outcomes 13 studies in 69 results
-
Systemic Lupus Erythematosus (Libman-Sacks Disease)
:
14 outcomes 11 studies in 100 results
-
Proteinuria
:
13 outcomes 9 studies in 63 results
-
Graft vs Host Disease (Graft-Versus-Host Disease)
:
11 outcomes 6 studies in 191 results
Show All >>
Drugs Related to mycophenolate mofetil
-
Cyclophosphamide (Cytoxan)
-
Cyclosporine (Ciclosporin)
-
Azathioprine (Imuran)
-
Adrenal Cortex Hormones (Corticosteroids)
-
Tacrolimus (Prograf)
-
Prednisone (Sone)
-
Methotrexate (Mexate)
-
rituximab (Mabthera)
-
Prednisolone (Predate)
-
Steroids
Show All >>
Therapies Related to mycophenolate mofetil
-
Homologous Transplantation (Allograft)
-
Transplantation (Transplant Recipients)
-
Kidney Transplantation
-
Liver Transplantation
-
Transplants (Transplant)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.